WHO Officials Express ‘Cautious Optimism’ On Experimental Vaccine Use In DRC Ebola Outbreak Response
Associated Press: Health officials ‘cautiously optimistic’ on Ebola response
“The World Health Organization said Tuesday it is ‘cautiously optimistic’ about efforts to curb the spread of Ebola in an urban area in Congo, although the lethal virus is still reported in at least two remote areas…” (5/29).
CIDRAP News: Ebola outbreak response shifts to remote DRC hot spots
“…At a briefing in Geneva [Tuesday] live-streamed on the WHO’s Twitter feed, health officials also said DRC’s health ministry is finalizing protocols for testing five therapeutic treatments and that a trial of a second experimental Ebola vaccine — a prime-boost regimen developed by Johnson & Johnson — may take place in the outbreak setting…” (Schnirring, 5/29).
Reuters: Almost all in Congo city at immediate risk of Ebola now vaccinated — WHO
“The World Health Organization said on Tuesday almost all the people it considers at immediate risk from an Ebola outbreak in the Democratic Republic of Congo city of Mbandaka have now been vaccinated against the disease…” (Miles, 5/29).
STAT: Ebola outbreak opens way to chaotic jockeying to test experimental drugs
“Companies and other players involved in the development of experimental Ebola drugs are jockeying to have their products tested in the outbreak in the Democratic Republic of the Congo, part of a chaotic and politically charged effort to use them in the midst of a crisis. With one vaccine already being used in the field, plans are underway to see if another might also be tested. And as many as five drugs, most of which are not supported by much human data, could be used in head-to-head trials…” (Branswell, 5/30).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.